Annual Operating Profit
$8.81 B
-$2.16 B-19.72%
31 December 2023
Summary:
Gilead Sciences annual operaing income is currently $8.81 billion, with the most recent change of -$2.16 billion (-19.72%) on 31 December 2023. During the last 3 years, it has fallen by -$2.05 billion (-18.85%). GILD annual operating profit is now -60.30% below its all-time high of $22.19 billion, reached on 31 December 2015.GILD Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
$3.14 B
+$462.00 M+17.23%
30 September 2024
Summary:
Gilead Sciences quarterly operating income is currently $3.14 billion, with the most recent change of +$462.00 million (+17.23%) on 30 September 2024. Over the past year, it has increased by +$1.14 billion (+56.52%). GILD quarterly operating profit is now -44.08% below its all-time high of $5.62 billion, reached on 31 December 2015.GILD Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
$7.64 B
+$430.00 M+5.96%
30 September 2024
Summary:
Gilead Sciences TTM operating income is currently $7.64 billion, with the most recent change of +$430.00 million (+5.96%) on 30 September 2024. Over the past year, it has dropped by -$1.17 billion (-13.24%). GILD TTM operating profit is now -65.57% below its all-time high of $22.19 billion, reached on 31 December 2015.GILD TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GILD Operating Profit Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | +56.5% | -13.2% |
3 y3 years | -18.9% | +95.3% | -29.6% |
5 y5 years | -5.7% | +66.0% | -17.1% |
GILD Operating Profit High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -19.7% | at low | -38.7% | +1745.5% | -41.0% | +18.8% |
5 y | 5 years | -19.7% | at low | -38.7% | +1745.5% | -41.0% | +18.8% |
alltime | all time | -60.3% | +7399.8% | -44.1% | +1745.5% | -65.6% | +6431.1% |
Gilead Sciences Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $3.14 B(+17.2%) | $7.64 B(+6.0%) |
June 2024 | - | $2.68 B(-1503.7%) | $7.21 B(+12.1%) |
Mar 2024 | - | -$191.00 M(-109.5%) | $6.43 B(-27.0%) |
Dec 2023 | $8.81 B(-19.7%) | $2.01 B(-26.0%) | $8.81 B(-26.1%) |
Sept 2023 | - | $2.71 B(+42.7%) | $11.92 B(-4.6%) |
June 2023 | - | $1.90 B(-13.0%) | $12.50 B(-3.5%) |
Mar 2023 | - | $2.19 B(-57.4%) | $12.95 B(+18.0%) |
Dec 2022 | $10.97 B(+1.1%) | $5.13 B(+56.0%) | $10.97 B(+47.1%) |
Sept 2022 | - | $3.29 B(+39.3%) | $7.46 B(-7.7%) |
June 2022 | - | $2.36 B(+1050.7%) | $8.08 B(-0.3%) |
Mar 2022 | - | $205.00 M(-87.3%) | $8.11 B(-25.3%) |
Dec 2021 | $10.86 B(+9.4%) | $1.61 B(-58.8%) | $10.85 B(-9.2%) |
Sept 2021 | - | $3.91 B(+63.9%) | $11.96 B(+6.5%) |
June 2021 | - | $2.38 B(-19.2%) | $11.22 B(+8.1%) |
Mar 2021 | - | $2.95 B(+8.7%) | $10.38 B(+4.6%) |
Dec 2020 | $9.93 B(+6.3%) | $2.71 B(-14.4%) | $9.93 B(+9.0%) |
Sept 2020 | - | $3.17 B(+105.8%) | $9.11 B(+8.1%) |
June 2020 | - | $1.54 B(-38.3%) | $8.42 B(-11.1%) |
Mar 2020 | - | $2.50 B(+32.0%) | $9.47 B(+2.8%) |
Dec 2019 | $9.34 B(+0.4%) | $1.89 B(-23.9%) | $9.21 B(-3.7%) |
Sept 2019 | - | $2.49 B(-4.2%) | $9.56 B(-1.4%) |
June 2019 | - | $2.60 B(+16.0%) | $9.70 B(+3.4%) |
Mar 2019 | - | $2.24 B(-0.2%) | $9.38 B(+0.9%) |
Dec 2018 | $9.30 B(-34.2%) | $2.24 B(-14.5%) | $9.30 B(-0.5%) |
Sept 2018 | - | $2.62 B(+15.0%) | $9.35 B(-11.3%) |
June 2018 | - | $2.28 B(+5.9%) | $10.54 B(-15.8%) |
Mar 2018 | - | $2.15 B(-6.0%) | $12.51 B(-11.4%) |
Dec 2017 | $14.12 B(-19.9%) | $2.29 B(-39.9%) | $14.12 B(-11.0%) |
Sept 2017 | - | $3.81 B(-10.4%) | $15.88 B(-3.6%) |
June 2017 | - | $4.25 B(+12.9%) | $16.46 B(-1.7%) |
Mar 2017 | - | $3.77 B(-6.9%) | $16.75 B(-5.0%) |
Dec 2016 | $17.63 B(-20.5%) | $4.04 B(-8.0%) | $17.63 B(-8.2%) |
Sept 2016 | - | $4.40 B(-3.1%) | $19.21 B(-5.8%) |
June 2016 | - | $4.54 B(-2.4%) | $20.39 B(-5.0%) |
Mar 2016 | - | $4.65 B(-17.3%) | $21.47 B(-3.2%) |
Dec 2015 | $22.19 B(+45.4%) | $5.62 B(+0.6%) | $22.19 B(+6.2%) |
Sept 2015 | - | $5.58 B(-0.6%) | $20.90 B(+11.2%) |
June 2015 | - | $5.62 B(+4.6%) | $18.80 B(+6.8%) |
Mar 2015 | - | $5.37 B(+24.0%) | $17.59 B(+15.3%) |
Dec 2014 | $15.27 B(+237.4%) | $4.33 B(+24.4%) | $15.27 B(+25.8%) |
Sept 2014 | - | $3.48 B(-21.1%) | $12.13 B(+23.8%) |
June 2014 | - | $4.41 B(+45.0%) | $9.80 B(+49.8%) |
Mar 2014 | - | $3.04 B(+154.2%) | $6.54 B(+44.6%) |
Dec 2013 | $4.52 B(+12.8%) | $1.20 B(+4.3%) | $4.52 B(+2.0%) |
Sept 2013 | - | $1.15 B(-0.5%) | $4.43 B(+2.4%) |
June 2013 | - | $1.15 B(+12.5%) | $4.33 B(+2.2%) |
Mar 2013 | - | $1.03 B(-7.4%) | $4.24 B(+5.6%) |
Dec 2012 | $4.01 B(+5.8%) | $1.11 B(+6.0%) | $4.01 B(+6.3%) |
Sept 2012 | - | $1.04 B(-1.4%) | $3.77 B(+1.1%) |
June 2012 | - | $1.06 B(+32.4%) | $3.73 B(+1.1%) |
Mar 2012 | - | $800.19 M(-7.8%) | $3.69 B(-2.7%) |
Dec 2011 | $3.79 B(-4.4%) | $867.48 M(-13.6%) | $3.79 B(+1.0%) |
Sept 2011 | - | $1.00 B(-1.3%) | $3.75 B(+0.7%) |
June 2011 | - | $1.02 B(+12.7%) | $3.73 B(+0.7%) |
Mar 2011 | - | $901.97 M(+8.8%) | $3.70 B(-6.5%) |
Dec 2010 | $3.96 B(+12.3%) | $829.38 M(-15.3%) | $3.96 B(-5.6%) |
Sept 2010 | - | $979.07 M(-1.4%) | $4.20 B(+2.1%) |
June 2010 | - | $992.63 M(-14.5%) | $4.11 B(+6.0%) |
Mar 2010 | - | $1.16 B(+9.0%) | $3.88 B(+10.0%) |
Dec 2009 | $3.53 B(+31.2%) | $1.07 B(+19.1%) | $3.53 B(+11.2%) |
Sept 2009 | - | $894.41 M(+17.5%) | $3.17 B(+6.7%) |
June 2009 | - | $761.06 M(-5.8%) | $2.97 B(+5.1%) |
Mar 2009 | - | $808.32 M(+13.7%) | $2.83 B(+5.2%) |
Dec 2008 | $2.69 B(+24.2%) | $711.15 M(+2.5%) | $2.69 B(+7.9%) |
Sept 2008 | - | $693.83 M(+12.6%) | $2.49 B(+6.3%) |
June 2008 | - | $616.37 M(-7.7%) | $2.35 B(+3.2%) |
Mar 2008 | - | $668.05 M(+29.8%) | $2.27 B(+5.0%) |
Dec 2007 | $2.16 B | $514.49 M(-5.9%) | $2.16 B(+1.4%) |
Sept 2007 | - | $547.03 M(+0.8%) | $2.14 B(+6.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2007 | - | $542.85 M(-3.1%) | $2.00 B(+9.7%) |
Mar 2007 | - | $560.14 M(+15.4%) | $1.82 B(+11.5%) |
Dec 2006 | $1.64 B(+47.4%) | $485.22 M(+17.5%) | $1.64 B(+8.3%) |
Sept 2006 | - | $413.11 M(+13.1%) | $1.51 B(+12.3%) |
June 2006 | - | $365.31 M(-1.7%) | $1.35 B(+7.0%) |
Mar 2006 | - | $371.65 M(+3.3%) | $1.26 B(+13.4%) |
Dec 2005 | $1.11 B(+76.8%) | $359.84 M(+45.0%) | $1.11 B(+21.8%) |
Sept 2005 | - | $248.25 M(-10.5%) | $910.22 M(+10.2%) |
June 2005 | - | $277.50 M(+24.2%) | $825.74 M(+16.9%) |
Mar 2005 | - | $223.48 M(+38.8%) | $706.44 M(+12.6%) |
Dec 2004 | $627.39 M(+90.2%) | $161.00 M(-1.7%) | $627.39 M(+13.2%) |
Sept 2004 | - | $163.77 M(+3.5%) | $554.37 M(+18.0%) |
June 2004 | - | $158.20 M(+9.5%) | $469.77 M(+12.0%) |
Mar 2004 | - | $144.42 M(+64.2%) | $419.35 M(+27.1%) |
Dec 2003 | $329.92 M(+307.3%) | $87.98 M(+11.1%) | $329.92 M(+20.1%) |
Sept 2003 | - | $79.17 M(-26.5%) | $274.79 M(+18.7%) |
June 2003 | - | $107.77 M(+95.9%) | $231.53 M(+62.0%) |
Mar 2003 | - | $55.00 M(+67.5%) | $142.95 M(+76.5%) |
Dec 2002 | $81.01 M(-167.1%) | $32.84 M(-8.6%) | $81.01 M(+248.5%) |
Sept 2002 | - | $35.92 M(+87.1%) | $23.24 M(-147.7%) |
June 2002 | - | $19.19 M(-376.5%) | -$48.74 M(-52.1%) |
Mar 2002 | - | -$6.94 M(-72.1%) | -$101.83 M(-15.6%) |
Dec 2001 | -$120.69 M(+130.7%) | -$24.92 M(-30.9%) | -$120.69 M(+5.5%) |
Sept 2001 | - | -$36.07 M(+6.4%) | -$114.42 M(+15.2%) |
June 2001 | - | -$33.90 M(+31.4%) | -$99.29 M(+39.8%) |
Mar 2001 | - | -$25.80 M(+38.3%) | -$71.03 M(+43.0%) |
Dec 2000 | -$52.32 M(+1.2%) | -$18.65 M(-10.9%) | -$49.68 M(+119.5%) |
Sept 2000 | - | -$20.94 M(+271.6%) | -$22.63 M(-31.2%) |
June 2000 | - | -$5.63 M(+26.6%) | -$32.89 M(-17.0%) |
Mar 2000 | - | -$4.45 M(-153.0%) | -$39.62 M(-23.4%) |
Dec 1999 | -$51.70 M(-34.0%) | $8.40 M(-126.9%) | -$51.72 M(-36.2%) |
Sept 1999 | - | -$31.20 M(+152.4%) | -$81.02 M(+13.4%) |
June 1999 | - | -$12.36 M(-25.3%) | -$71.42 M(-9.4%) |
Mar 1999 | - | -$16.55 M(-20.8%) | -$78.85 M(+5.8%) |
Dec 1998 | -$78.30 M(+8.6%) | -$20.90 M(-3.2%) | -$74.50 M(-23.4%) |
Sept 1998 | - | -$21.60 M(+9.1%) | -$97.20 M(+7.2%) |
June 1998 | - | -$19.80 M(+62.3%) | -$90.70 M(+25.4%) |
Mar 1998 | - | -$12.20 M(-72.0%) | -$72.30 M(+0.4%) |
Dec 1997 | -$72.10 M(+99.7%) | -$43.60 M(+188.7%) | -$72.00 M(+76.9%) |
Sept 1997 | - | -$15.10 M(+978.6%) | -$40.70 M(+102.5%) |
June 1997 | - | -$1.40 M(-88.2%) | -$20.10 M(-41.9%) |
Mar 1997 | - | -$11.90 M(-3.3%) | -$34.60 M(-3.9%) |
Dec 1996 | -$36.10 M(+12.8%) | -$12.30 M(-323.6%) | -$36.00 M(+51.9%) |
Sept 1996 | - | $5.50 M(-134.6%) | -$23.70 M(-39.4%) |
June 1996 | - | -$15.90 M(+19.5%) | -$39.10 M(+21.4%) |
Mar 1996 | - | -$13.30 M(+34.3%) | -$32.20 M(-15.5%) |
Dec 1995 | -$32.00 M(-9.1%) | - | - |
Sept 1995 | - | -$9.90 M(+10.0%) | -$38.10 M(+5.5%) |
June 1995 | - | -$9.00 M(-10.0%) | -$36.10 M(+2.6%) |
Mar 1995 | - | -$10.00 M(+8.7%) | -$35.20 M(+2.6%) |
Mar 1995 | -$35.20 M(+19.3%) | - | - |
Dec 1994 | - | -$9.20 M(+16.5%) | -$34.30 M(+4.9%) |
Sept 1994 | - | -$7.90 M(-2.5%) | -$32.70 M(+3.5%) |
June 1994 | - | -$8.10 M(-11.0%) | -$31.60 M(+7.8%) |
Mar 1994 | -$29.50 M(+62.1%) | -$9.10 M(+19.7%) | -$29.30 M(+8.1%) |
Dec 1993 | - | -$7.60 M(+11.8%) | -$27.10 M(+11.5%) |
Sept 1993 | - | -$6.80 M(+17.2%) | -$24.30 M(+14.6%) |
June 1993 | - | -$5.80 M(-15.9%) | -$21.20 M(+16.5%) |
Mar 1993 | -$18.20 M(+188.9%) | -$6.90 M(+43.8%) | -$18.20 M(-1.6%) |
Dec 1992 | - | -$4.80 M(+29.7%) | -$18.50 M(+40.2%) |
Sept 1992 | - | -$3.70 M(+32.1%) | -$13.20 M(+41.9%) |
June 1992 | - | -$2.80 M(-61.1%) | -$9.30 M(+47.6%) |
Mar 1992 | -$6.30 M(+31.3%) | -$7.20 M(-1540.0%) | -$6.30 M(+57.5%) |
Dec 1991 | - | $500.00 K(+150.0%) | -$4.00 M(-9.1%) |
Sept 1991 | - | $200.00 K(0.0%) | -$4.40 M(-2.2%) |
June 1991 | - | $200.00 K(-104.1%) | -$4.50 M(-2.2%) |
Mar 1991 | -$4.80 M | -$4.90 M(-5000.0%) | -$4.60 M(-1633.3%) |
Dec 1990 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
Sept 1990 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
June 1990 | - | $100.00 K | $100.00 K |
FAQ
- What is Gilead Sciences annual operaing income?
- What is the all time high annual operating profit for Gilead Sciences?
- What is Gilead Sciences quarterly operating income?
- What is the all time high quarterly operating profit for Gilead Sciences?
- What is Gilead Sciences quarterly operating profit year-on-year change?
- What is Gilead Sciences TTM operating income?
- What is the all time high TTM operating profit for Gilead Sciences?
- What is Gilead Sciences TTM operating profit year-on-year change?
What is Gilead Sciences annual operaing income?
The current annual operating profit of GILD is $8.81 B
What is the all time high annual operating profit for Gilead Sciences?
Gilead Sciences all-time high annual operaing income is $22.19 B
What is Gilead Sciences quarterly operating income?
The current quarterly operating profit of GILD is $3.14 B
What is the all time high quarterly operating profit for Gilead Sciences?
Gilead Sciences all-time high quarterly operating income is $5.62 B
What is Gilead Sciences quarterly operating profit year-on-year change?
Over the past year, GILD quarterly operating income has changed by +$1.14 B (+56.52%)
What is Gilead Sciences TTM operating income?
The current TTM operating profit of GILD is $7.64 B
What is the all time high TTM operating profit for Gilead Sciences?
Gilead Sciences all-time high TTM operating income is $22.19 B
What is Gilead Sciences TTM operating profit year-on-year change?
Over the past year, GILD TTM operating income has changed by -$1.17 B (-13.24%)